The listing was noteworthy not only for its size but for the market dynamics it revealed: a global shortage of memory chips that the company's own CEO forecasts could last beyond 2030, an aggressive capacity expansion plan fueled by the IPO proceeds, and a post-debut volatility that saw Seoul-listed shares suffer their worst single-day drop in nearly two decades.
SK Hynix sold 177.9 million American Depositary Shares (ADSs) at $149 each, raising approximately $26.5 billion . The ADRs opened at $170 on their first trading day, surging roughly 13-14% above the offer price
. By the following Tuesday, shares had climbed to $193.92, representing a gain of approximately 30% from the offer price and translating to roughly a 27% first-week rally
.
The offering was reportedly seven times oversubscribed by institutional investors . Underwriters included BofA Securities, Citigroup, Goldman Sachs, and J.P. Morgan
.
On the day of the Nasdaq listing, CEO Kwak Noh-jung delivered a stark forecast in his first-ever English-language interview: the global memory chip shortage "will probably persist beyond 2030" . He specifically predicted that 2027 will be the "worst year in the industry's history from the supply perspective"
.
"Our customer demand continues to go up, while our capacity... will not be able to catch up," Kwak told Reuters on July 10 . Customers are already signing long-term supply contracts because "they believe that the shortage situation will last for longer"
.
This warning echoed earlier statements from SK Group Chairman Chey Tae-won, who said in March and June 2026 that the memory chip crunch — driven by insatiable AI demand — could persist until 2030, with industry-wide wafer supply lagging demand by more than 20% .
SK Hynix plans to deploy the Nasdaq proceeds to fund an aggressive fabrication expansion. The company intends to double its total wafer capacity over the next five years to help alleviate the memory chip crunch .
In a move that underscores the scale of its ambition, SK Hynix placed an approximately $8 billion order with ASML for extreme ultraviolet (EUV) lithography machines — one of the largest single equipment orders in memory chip history. The deal involves the purchase of at least 20 EUV scanners, with deliveries scheduled through December 2027, to be deployed at the Cheongju M15X fab and the Yongin Semiconductor Cluster .
The engine behind SK Hynix's meteoric rise is its dominance in high-bandwidth memory (HBM), the specialized DRAM that is a critical component in Nvidia's AI accelerators. According to Counterpoint Research and other analysts, SK Hynix held approximately 57-58% of the global HBM market in the first quarter of 2026, with Samsung and Micron each controlling about 21% .
The company's lead extends into next-generation technology. SK Hynix has secured more than 70% of Nvidia's initial HBM4 orders for the upcoming "Vera Rubin" AI platform, cementing its position as Nvidia's primary HBM supplier . SK Hynix began mass production of HBM4 in February 2026
.
The financial results reflect this strategic position: SK Hynix posted an operating profit of 37.61 trillion won ($25 billion) in the first quarter of 2026, a 405% leap from a year earlier, with an operating margin reaching 72% .
The euphoria of the Nasdaq debut was tempered by a sharp correction in the company's Seoul-listed shares. On Monday, July 13, SK Hynix shares on the Korea Exchange tumbled more than 15% — their biggest one-day drop in nearly two decades — as domestic investors unwound gains from the stock's scorching rally, which had seen the shares more than triple in 2026 . U.S.-listed ADRs also fell 8.3% in premarket trading on that Monday, dropping to $154.10
.
An earlier dip occurred on July 12, when Seoul shares fell as much as 4.4%, and ADRs opened down 2.2% at $164.40 after the Friday surge . By mid-July, SK Hynix ADRs were trading at a premium of more than 50% over the Seoul-listed shares, driven by strong U.S. institutional demand and structural conversion limits
.
The available sources did not provide evidence for several claims included in the original inquiry. A Barclays analyst endorsement for SK Hynix's ADRs could not be confirmed from the documents captured. Similarly, reports of IBM issuing a warning about an AI-related spending shift, details on CXMT's IPO, the launch of a Roundhill Memory ETF, and a UBS ADR recommendation were not found in the retrieved sources.